Pattern visual evoked potential in newly diagnosed hypertensive individuals
Keywords:Hypertension, VEP, Subclinical Retinopathy, Newly Diagnosed.
Background: Neuronal dysfunction in hypertension with multifactorial aetiology involves white matter involvement and strongly associated with presence of retinal micro vascular lesions. Cortical lesions associated with optic nerve damage and retinopathy leads to visual disturbances. VEPs are the potential changes recorded from the scalp in response to visual stimuli. Since optic nerve is considered to be the part of brain, its subclinical involvement is likely hypertension. It is in this connection the present study involving visual evoked potential was done to see if there was any change in functional integrity of visual pathways in hypertension. The aim of the study was to evaluate the visual evoked potential in newly diagnosed hypertensive patients who have not taken any antihypertensive drugs before.
Methods: 50 cases were selected based on inclusion and exclusion criteria and compared with 50 age, sex matched controls. Study was conducted after getting informed consent, by using the Medicaid polyrite instrument and VEP readings had been taken by standard procedure.
Results: Study shows significant P100 latency when analysed through Levene’s test for equality of variances having p100 latencies for right eye 4.19±0.4 with p value of 0.003 and left eye 5.30±0.02 with p value of 0.000 substantiating prechiasmal lesion.
Conclusions: Statistically significant delay in p100 suggests that the development of hypertensive retinopathy sub clinically, occurs in very early stages of Hypertension, which is not detectable on routine clinical examination. VEP can be suggested for screening in high-risk individuals to evaluate the functional integrity of visual pathway in hypertension and as a key to unravel the mystery of hidden Hypertensive Morbidity and Mortality.
Das SK, “Study of urban community survey in India: growing trend of high prevalence of hypertension in developing country” Int J Med Sci. 2005;2(2):70-8.
Lewington S. “Age- specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies” Lancet. 2003;19(9366):1390-1.
Pemu PI. “Hypertension in Women: part I” J Clin Hypertens (Greeenwich). 2008;10(5):406-10.
Schmieder RE. “End Organ Damage In Hypertension” Dtsch Arztebl Int. 2010;107(49):866-73.
Wong TY. “HYPERTENSIVE RETINOPATHY” N Engl J Med. 2004;351:2310-7.
Wong TY. “Retinal microvascular abnormalities and blood pressure in older people: the cardiovascular health study” Br J Opthalmol. 2002;86:1007-13.
Triantafyllou A. “Association Between Retinal Vessel Caliber and Arterial Stiffness in a Population Comprised of normotensive To Early-Stage Hypertensive Individuals”. Am J Hupertens. 2014.
Grosso A. “Hypertensive retinopathy revisited: some answers, more questions” Br J Opthalmol. 2005;89:1646-54.
Resch M. “Hypertension-related eye disorders” Orv Hetil. 2013;154(45):1773-80.
Tormene AP. “Electrophysiological findings in anterior ischemic optic neuropathy” pubmed, Meteb pediatr syst opthalmol. 1989;12(1-3):76-9.
Sebire G. “encephalopathy induced by arterial hypertension: clinical, radiological and therapeutic aspects” . Arch Pediatr. 1995;2(6):512-8.
Hacioglu G. “The effect of different hypertension models on visual evoked potentials” International Journal of Neuroscience. Vol. 112, No.11. 2002,1321-35.
Gocemen AY. “The Relationship between oxidative stress markers and visual evoked potentials in different hypertension models” Anadolu Kardiyol Derg. 2014;14(6):498-504.
Guideline 10: Guidelines for Writing Clinical Evoked Potential Reports- Dec 2003, American Clinical Neurophysiology Society.
Isles CS. “Prevalence, epidemiology and pathology of hypertension” Oxford university press. 2000;1153-60.
Allison T. “Brainstem auditory, Pattern reversal visual and short latency somatosensory evoked potentials: latencies in relation to age, sex and brain and body size” Electroencephalogr Clin neurophysiol. 1983;55:619.
Nguyen TT. “Retinal vascular changes in pre-diabetes and prehypertension: new findings and their research and clinical implications” Diabetes care. 2007;30(10):2708-15.
Mulvany MJ. “Vascular Remodelling. Hypertension”-American Heart Association. 1996;28(3):505-6.
Tandon OP. “visual evoked potentials in primary hypertension” Indian J physiol pharmacol. 1997;41(2):154-8.
Cugini P. ‘minimal-change hypertensive retinopathy’ and ‘arterial hypertension’, illustrated via ambulatory blood pressure monitoring in putatively normotensive subjects” international ophthalmology 05. 1998;22(3);145-9.